Human iPS cell models of Jervell and Lange-Nielsen syndrome

References

• Zhang M, D'Aniello C, Verkerk AO, Wrobel E, Frank S, Ward-van Oostwaard D, Piccini I, Freund C, Rao J, Seebohm G, et al. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci U S A 2014; 111:E5383-92; PMID:25453094
   PubMed Web of Science ®Google Scholar
• Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102:1178-85; PMID:10973849; http://dx.doi.org/10.1161/01.CIR.102.10.1178
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89-95; PMID:11136691; http://dx.doi.org/10.1161/01.CIR.103.1.89
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, Berul CI, Bitner-Glindzicz M, Toivonen L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006; 113:783-90; PMID:16461811; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.592899
   PubMed Web of Science ®Google Scholar
• Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 2012; 13:713-26; PMID:23034453; http://dx.doi.org/10.1038/nrm3448
   PubMed Web of Science ®Google Scholar
• Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363:1397-409; PMID:20660394; http://dx.doi.org/10.1056/NEJMoa0908679
   PubMed Web of Science ®Google Scholar
• Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, Tohyama S, Okata S, Seki T, et al. Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 2012; 95:419-29; PMID:22739119; http://dx.doi.org/10.1093/cvr/cvs206
   PubMed Web of Science ®Google Scholar
• Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res 2001; 51:670-80; PMID:11530100; http://dx.doi.org/10.1016/S0008-6363(01)00350-9
   PubMed Web of Science ®Google Scholar
• Yang X, Pabon L, Murry CE. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014; 114:511-23; PMID:24481842; http://dx.doi.org/10.1161/CIRCRESAHA.114.300558
   PubMed Web of Science ®Google Scholar
• Zhang M, Schulte JS, Heinick A, Piccini I, Rao J, Quaranta R, Zeuschner D, Malan D, Kim KP, Ropke A, et al. Universal cardiac induction of human pluripotent stem cells in 2D and 3D formats - Implications for in-vitro maturation. Stem cells 2015; doi: 10.1002/stem.1964.
   Google Scholar
• Lee MP, Hu RJ, Johnson LA, Feinberg AP. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 1997; 15:181-5; PMID:9020845; http://dx.doi.org/10.1038/ng0297-181
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997; 336:1562-7; PMID:9164812; http://dx.doi.org/10.1056/NEJM199705293362204
   PubMed Web of Science ®Google Scholar
• Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004; 5:89-99; PMID:15040442; http://dx.doi.org/10.1038/nrm1310
   PubMed Web of Science ®Google Scholar
• Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 2006; 5:1034-49; PMID:17139288; http://dx.doi.org/10.1038/nrd2112
   PubMed Web of Science ®Google Scholar
• Morita H, Wu J, Zipes DP. The QT syndromes: long and short. Lancet 2008; 372:750-63; PMID:18761222; http://dx.doi.org/10.1016/S0140-6736(08)61307-0
   PubMed Web of Science ®Google Scholar
• Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP, Grunnet M. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 2006; 69:266-77; PMID:16219910
   PubMedGoogle Scholar
• Casis O, Olesen SP, Sanguinetti MC. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 2006; 69:658-65; PMID:16284303; http://dx.doi.org/10.1124/mol.105.019943
   PubMed Web of Science ®Google Scholar
• Xu X, Salata JJ, Wang J, Wu Y, Yan GX, Liu T, Marinchak RA, Kowey PR. Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2002; 283:H664-70; PMID:12124214
   PubMed Web of Science ®Google Scholar
• Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, Sharma A, Burridge PW, Patlolla B, Lee AS, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation 2013; 128:S3-13
   PubMed Web of Science ®Google Scholar
• Chi KR. Revolution dawning in cardiotoxicity testing. Nature Rev Drug Discov 2013; 12:565-7; PMID:23903208; http://dx.doi.org/10.1038/nrd4083
   PubMed Web of Science ®Google Scholar
• Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R, Mummery CL. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010; 4:107-16; PMID:20034863; http://dx.doi.org/10.1016/j.scr.2009.11.004
   PubMed Web of Science ®Google Scholar